# METFORMIN HYDROCHLORIDE
> **ANDA209993** · Abbreviated New Drug Application (Generic) · Sponsor: QINGDAO BAHEAL PHARM · Approved 2018-12-27
## Drug
- **FDA Application Number:** ANDA209993
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METFORMIN HYDROCHLORIDE
- **Generic name:** METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS
- **Active ingredients:** METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** QINGDAO BAHEAL PHARM
- **Manufacturer:** Qingdao BAHEAL Pharmaceutical Co., Ltd.
- **First approval:** 2018-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209993)
---
*AI Analytics · CC0 1.0*